Sanofi was pleased to invite investors and analysts to attend its Vaccines Investor Event on Wednesday, December 1, 2021. This event provided an in-depth look at our Vaccines business: how we expect the vaccine market to evolve and our strategy to continue to be a strong growth driver through an innovative R&D pipeline.
Webcast Replay Vaccines: What's Next - Part 1
Webcast Replay Vaccines: What's Next - Part 2
"We’re building a highly innovative pipeline to address unmet needs by providing new vaccines solutions and unlocking the potential of mRNA"
Thomas Triomphe, Sanofi's EVP for Vaccines